Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
52.7M
-
Shares change
-
-1.08M
-
Total reported value, excl. options
-
$382M
-
Value change
-
-$12.5M
-
Put/Call ratio
-
0.98
-
Number of buys
-
95
-
Number of sells
-
-97
-
Price
-
$7.25
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2023
286 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q1 2023.
Editas Medicine, Inc. - Common Stock (EDIT) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7M shares
of 82.8M outstanding shares and own 63.64% of the company stock.
Largest 10 shareholders include STATE STREET CORP (8.16M shares), BlackRock Inc. (7.42M shares), VANGUARD GROUP INC (7.2M shares), Woodline Partners LP (2.65M shares), CITADEL ADVISORS LLC (1.62M shares), DIMENSIONAL FUND ADVISORS LP (1.61M shares), GEODE CAPITAL MANAGEMENT, LLC (1.45M shares), MILLENNIUM MANAGEMENT LLC (1.28M shares), JPMORGAN CHASE & CO (1.13M shares), and PICTET ASSET MANAGEMENT SA (1.06M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.